Skip to main content
Top
Published in: International Journal of Hematology 2/2018

01-02-2018 | Original Article

Persistent changes in circulating white blood cell populations after splenectomy

Authors: Minke A. E. Rab, Aafke Meerveld-Eggink, Heleen van Velzen-Blad, Douwe van Loon, Ger T. Rijkers, Okke de Weerdt

Published in: International Journal of Hematology | Issue 2/2018

Login to get access

Abstract

The effect of splenectomy on the incidence of infections and thromboembolisms has been investigated thoroughly. Nevertheless, the long-term effects of splenectomy on immunological profile and circulating blood counts have not been described before. To study such long-term effects, we analysed several parameters in splenectomised trauma patients and compared the results of this group (“otherwise healthy patients”) to patients with a specific underlying disease. We measured platelet count, leukocytes and differential, lymphocyte subsets, serum levels of immunoglobulins, and complement pathways in 113 patients. Indications to perform a splenectomy were trauma (n = 42), Hodgkin lymphoma (n = 24), hereditary spherocytosis (n = 21), and immune thrombocytopenia (n = 26). In trauma patients lymphocytes and lymphocytes subsets were particularly elevated compared to normal population values. Splenectomised patients with Hodgkin lymphoma had significant lower numbers of T lymphocytes than trauma patients. Significant increases in platelets, leukocytes, and monocytes were observed in patients with hereditary spherocytosis. Occurrence of MBL genotype was different in ITP patients than in other splenectomised groups and the normal population. In splenectomised patients (> 4 years), platelet counts and lymphocyte subsets are increased which persist over time. As a result, these blood counts in splenectomised patients differ from reference values in the normal population.
Literature
1.
go back to reference Davies JM, Lewis MPN, Wimperis J, Rafi I, Ladhani S, Bolton-Maggs PHB. Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a Working Party of the Haemato-Oncology Task Force. Br J Haematol. 2011;155:308–17.CrossRefPubMed Davies JM, Lewis MPN, Wimperis J, Rafi I, Ladhani S, Bolton-Maggs PHB. Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a Working Party of the Haemato-Oncology Task Force. Br J Haematol. 2011;155:308–17.CrossRefPubMed
2.
go back to reference Toutouzas KG, Velmahos GC, Kaminski A, Chan L, Demetriades D. Leukocytosis after posttraumatic splenectomy. Arch Surg. 2002;137:924–8.CrossRefPubMed Toutouzas KG, Velmahos GC, Kaminski A, Chan L, Demetriades D. Leukocytosis after posttraumatic splenectomy. Arch Surg. 2002;137:924–8.CrossRefPubMed
3.
go back to reference Weng J, Brown CVR, Rhee P, Salim A, Chan L, Demetriades D, et al. White blood cell and platelet counts can be used to differentiate between infection and the normal response after splenectomy for trauma: prospective validation. J Trauma Inj Infect Crit Care. 2005;117:1076–80.CrossRef Weng J, Brown CVR, Rhee P, Salim A, Chan L, Demetriades D, et al. White blood cell and platelet counts can be used to differentiate between infection and the normal response after splenectomy for trauma: prospective validation. J Trauma Inj Infect Crit Care. 2005;117:1076–80.CrossRef
4.
go back to reference Banerjee A, Kelly KB, Zhou HY, Dixon SD, Papana Dagiasis A, Quinn LM, et al. Diagnosis of Infection after splenectomy for trauma should be based on lack of platelets rather than white blood cell count. Surg Infect. 2014;15:221–6.CrossRef Banerjee A, Kelly KB, Zhou HY, Dixon SD, Papana Dagiasis A, Quinn LM, et al. Diagnosis of Infection after splenectomy for trauma should be based on lack of platelets rather than white blood cell count. Surg Infect. 2014;15:221–6.CrossRef
5.
go back to reference Cameron PU, Jones P, Gorniak M, Dunster K, Paul E, Lewin S, et al. Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort. PLoS One. 2011;6:e23164.CrossRefPubMedPubMedCentral Cameron PU, Jones P, Gorniak M, Dunster K, Paul E, Lewin S, et al. Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort. PLoS One. 2011;6:e23164.CrossRefPubMedPubMedCentral
6.
go back to reference Meerveld-Eggink A, de Weerdt O, de Voer RM, Berbers GAM, van Velzen-Blad H, Vlaminckx BJ, et al. Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients. Eur J Clin Microbiol Infect Dis. 2011;30:611–8.CrossRefPubMed Meerveld-Eggink A, de Weerdt O, de Voer RM, Berbers GAM, van Velzen-Blad H, Vlaminckx BJ, et al. Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients. Eur J Clin Microbiol Infect Dis. 2011;30:611–8.CrossRefPubMed
7.
go back to reference Meerveld-Eggink A, de Weerdt O, van Velzen-Blad H, Biesma DH, Rijkers GT. Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients. Vaccine. 2011;29:675–80.CrossRefPubMed Meerveld-Eggink A, de Weerdt O, van Velzen-Blad H, Biesma DH, Rijkers GT. Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients. Vaccine. 2011;29:675–80.CrossRefPubMed
8.
go back to reference Meerveld-Eggink A, de Weerdt O, Rijkers GT, van Velzen-Blad H, Biesma DH. Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands. Vaccine. 2008;26:6975–9.CrossRefPubMed Meerveld-Eggink A, de Weerdt O, Rijkers GT, van Velzen-Blad H, Biesma DH. Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands. Vaccine. 2008;26:6975–9.CrossRefPubMed
9.
go back to reference Comans-Bitter WM, De Groot R, Van den Beemd R, Neijens HJ, Hop WCJ, Groeneveld K, et al. Immunophenotyping of blood lymphocytes in childhood: reference values for lymphocyte subpopulations. J Pediatr. 1997;130:388–93.CrossRefPubMed Comans-Bitter WM, De Groot R, Van den Beemd R, Neijens HJ, Hop WCJ, Groeneveld K, et al. Immunophenotyping of blood lymphocytes in childhood: reference values for lymphocyte subpopulations. J Pediatr. 1997;130:388–93.CrossRefPubMed
10.
go back to reference Vlug A, Nieuwenhuys E, van Eijk R, Geertzen H, van Houte A. Nephelometric measurements of human IgG subclasses and their reference ranges. Ann Biol Clin. 1994;52(7–8):561–7. Vlug A, Nieuwenhuys E, van Eijk R, Geertzen H, van Houte A. Nephelometric measurements of human IgG subclasses and their reference ranges. Ann Biol Clin. 1994;52(7–8):561–7.
11.
go back to reference Seelen MW, Roos A, Wieslander J, Mollnes TE, Sjöholm G, Wurzner R, et al. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods. 2005;296:187–98.CrossRefPubMed Seelen MW, Roos A, Wieslander J, Mollnes TE, Sjöholm G, Wurzner R, et al. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods. 2005;296:187–98.CrossRefPubMed
12.
go back to reference Endeman H, Herpers BL, De Jong BW, Voorn GP, Grutters JC, Van Velzen-Blad H, et al. Mannose-binding lectin genotypes in susceptibility to community-acquired pneumonia. Chest. 2008;134:1135–40.CrossRefPubMed Endeman H, Herpers BL, De Jong BW, Voorn GP, Grutters JC, Van Velzen-Blad H, et al. Mannose-binding lectin genotypes in susceptibility to community-acquired pneumonia. Chest. 2008;134:1135–40.CrossRefPubMed
13.
go back to reference Schoonen MW, Kucera G, Coalson J, Li L, Rutstein M, Mowat F, et al. Epidemiology of immune thrombocytopenic purpura in the general practice research database. Br J Haematol. 2009;145:235–44.CrossRefPubMed Schoonen MW, Kucera G, Coalson J, Li L, Rutstein M, Mowat F, et al. Epidemiology of immune thrombocytopenic purpura in the general practice research database. Br J Haematol. 2009;145:235–44.CrossRefPubMed
14.
go back to reference Blum KS, Pabst R. Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs? Immunol Lett. 2007;108:45–51.CrossRefPubMed Blum KS, Pabst R. Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs? Immunol Lett. 2007;108:45–51.CrossRefPubMed
15.
go back to reference Bessler H, Bergman M, Salman H, Beilin B, Djaldetti M. The relationship between partial splenectomy and peripheral leukocyte count. J Surg Res. 2004;122:49–53.CrossRefPubMed Bessler H, Bergman M, Salman H, Beilin B, Djaldetti M. The relationship between partial splenectomy and peripheral leukocyte count. J Surg Res. 2004;122:49–53.CrossRefPubMed
16.
go back to reference Miko I, Nemeth N, Sajtos E, Brath E, Peto K, Furka A, et al. Splenic function and red blood cell deformability: the beneficial effects of spleen autotransplantation in animal experiments. Clin Hemorheol Microcirc. 2010;45:281–8.PubMed Miko I, Nemeth N, Sajtos E, Brath E, Peto K, Furka A, et al. Splenic function and red blood cell deformability: the beneficial effects of spleen autotransplantation in animal experiments. Clin Hemorheol Microcirc. 2010;45:281–8.PubMed
17.
go back to reference Sipka S, Bráth E, Tóth FF, Aleksza M, Kulcsár A, Fábián A, et al. Cellular and serological changes in the peripheral blood of splenectomized and spleen autotransplanted mice. Transpl Immunol. 2006;16:99–104.CrossRefPubMed Sipka S, Bráth E, Tóth FF, Aleksza M, Kulcsár A, Fábián A, et al. Cellular and serological changes in the peripheral blood of splenectomized and spleen autotransplanted mice. Transpl Immunol. 2006;16:99–104.CrossRefPubMed
18.
go back to reference Seabrook TJ, Hein WR, Dudler L, Young AJ. Splenectomy selectively affects the distribution and mobility of the recirculating lymphocyte pool. Blood. 2000;96:1180–3.PubMed Seabrook TJ, Hein WR, Dudler L, Young AJ. Splenectomy selectively affects the distribution and mobility of the recirculating lymphocyte pool. Blood. 2000;96:1180–3.PubMed
19.
go back to reference Chaimoff C, Douer D, Pick IA, Pinkhas J. Serum lmmunoglobulin changes after accidental splenectomy in adults. Am J Surg Surg. 1978;136:332–3.CrossRef Chaimoff C, Douer D, Pick IA, Pinkhas J. Serum lmmunoglobulin changes after accidental splenectomy in adults. Am J Surg Surg. 1978;136:332–3.CrossRef
20.
go back to reference Order SE. The effects of therapeutic irradiation on lymphocytes and immunity. Cancer. 1977;39:737–43.CrossRefPubMed Order SE. The effects of therapeutic irradiation on lymphocytes and immunity. Cancer. 1977;39:737–43.CrossRefPubMed
21.
go back to reference Bjorkholm M, Holm G, Hospital S. Persisting lymphocyte deficiences during remission in Hodgkin’ s disease. Clin Exp Immunol. 1977;28:389–93.PubMedPubMedCentral Bjorkholm M, Holm G, Hospital S. Persisting lymphocyte deficiences during remission in Hodgkin’ s disease. Clin Exp Immunol. 1977;28:389–93.PubMedPubMedCentral
22.
go back to reference Fuks Z, Strober S, Bobrove AM, Sasazuki T, McMichael A, Kaplan HS. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin’s disease. J Clin Invest. 1976;58:803–14.CrossRefPubMedPubMedCentral Fuks Z, Strober S, Bobrove AM, Sasazuki T, McMichael A, Kaplan HS. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin’s disease. J Clin Invest. 1976;58:803–14.CrossRefPubMedPubMedCentral
23.
go back to reference Bjorkholm M, Askergren J, Holm G, Mellstedt H. Long-term influence of splenectomy on immune functions in patients with Hodgkins disease. Scand J Haematol. 1980;24:87–94.CrossRefPubMed Bjorkholm M, Askergren J, Holm G, Mellstedt H. Long-term influence of splenectomy on immune functions in patients with Hodgkins disease. Scand J Haematol. 1980;24:87–94.CrossRefPubMed
24.
25.
go back to reference Van Den Broek T, Delemarre EM, Janssen WJM, Nievelstein RAJ, Broen JC, Tesselaar K, et al. Neonatal thymectomy reveals differentiation and plasticity within human naive T cells. J Clin Invest. 2016;126:1–11. Van Den Broek T, Delemarre EM, Janssen WJM, Nievelstein RAJ, Broen JC, Tesselaar K, et al. Neonatal thymectomy reveals differentiation and plasticity within human naive T cells. J Clin Invest. 2016;126:1–11.
26.
go back to reference Troendle SB, Adix L, Crary SE, Buchanan GR. Laboratory markers of thrombosis risk in children with hereditary spherocytosis. Pediatr Blood Cancer. 2007;49:781–5.CrossRefPubMed Troendle SB, Adix L, Crary SE, Buchanan GR. Laboratory markers of thrombosis risk in children with hereditary spherocytosis. Pediatr Blood Cancer. 2007;49:781–5.CrossRefPubMed
27.
go back to reference Das A, Bansal D, Ahluwalia J, Das R, Rohit MK, Attri SV, Trehan AMR. Risk factors for thromboembolism and pulmonary artery hypertension following splenectomy in children with hereditary spherocytosis. Pediatr Blood Cancer. 2014;61:29–33.CrossRefPubMed Das A, Bansal D, Ahluwalia J, Das R, Rohit MK, Attri SV, Trehan AMR. Risk factors for thromboembolism and pulmonary artery hypertension following splenectomy in children with hereditary spherocytosis. Pediatr Blood Cancer. 2014;61:29–33.CrossRefPubMed
28.
go back to reference Schilling RF, Gangnon RE, Traver MI. Delayed adverse vascular events after splenectomy in hereditary spherocytosis. J Thromb Haemost. 2008;6:1289–95.CrossRefPubMed Schilling RF, Gangnon RE, Traver MI. Delayed adverse vascular events after splenectomy in hereditary spherocytosis. J Thromb Haemost. 2008;6:1289–95.CrossRefPubMed
30.
go back to reference Tsutsumi A, Takahashi R, Sumida T. Mannose binding lectin: genetics and autoimmune disease. Autoimmun Rev. 2005;4:364–72.CrossRefPubMed Tsutsumi A, Takahashi R, Sumida T. Mannose binding lectin: genetics and autoimmune disease. Autoimmun Rev. 2005;4:364–72.CrossRefPubMed
31.
go back to reference Pehlivan M, Okan V, Sever T, Balci SO, Yilmaz M, Babacan T. Investiagtion of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura. Platelets. 2011;22:588–95.CrossRefPubMed Pehlivan M, Okan V, Sever T, Balci SO, Yilmaz M, Babacan T. Investiagtion of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura. Platelets. 2011;22:588–95.CrossRefPubMed
32.
go back to reference Lammers AJJ, de Porto APNA, Bennink RJ, van Leeuwen EMM, Biemond BJ, Goslings JC, et al. Hyposplenism: comparison of different methods for determining splenic function. Am J Hematol. 2012;87:484–9.CrossRefPubMed Lammers AJJ, de Porto APNA, Bennink RJ, van Leeuwen EMM, Biemond BJ, Goslings JC, et al. Hyposplenism: comparison of different methods for determining splenic function. Am J Hematol. 2012;87:484–9.CrossRefPubMed
33.
go back to reference Marques RG, Lucena SBSG, Caetano CER, De Sousa VO, Portela MC, Petroianu A. Blood clearance of Howell-Jolly bodies in an experimental autogenic splenic implant model. Br J Surg. 2014;101:820–7.CrossRefPubMed Marques RG, Lucena SBSG, Caetano CER, De Sousa VO, Portela MC, Petroianu A. Blood clearance of Howell-Jolly bodies in an experimental autogenic splenic implant model. Br J Surg. 2014;101:820–7.CrossRefPubMed
Metadata
Title
Persistent changes in circulating white blood cell populations after splenectomy
Authors
Minke A. E. Rab
Aafke Meerveld-Eggink
Heleen van Velzen-Blad
Douwe van Loon
Ger T. Rijkers
Okke de Weerdt
Publication date
01-02-2018
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2018
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-017-2335-9

Other articles of this Issue 2/2018

International Journal of Hematology 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine